Treace Medical Concepts, Inc. (NasdaqGS:TMCI) entered into an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC for $30 million on June 1, 2023. As reported, the purchase price is $20 million in an upfront cash payment, with up to $10 million in potential milestone payments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | -1.20% | +9.05% | -61.25% |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
May. 16 | UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.25% | 310M | |
+73.10% | 12.39B | |
-19.92% | 7.89B | |
+8.05% | 6.59B | |
+12.49% | 5.43B | |
+40.80% | 4.96B | |
-17.45% | 4.72B | |
-20.17% | 4.02B | |
-28.94% | 2.66B | |
+61.09% | 2.37B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. entered into an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC for $30 million.